Clinical Trials:
Colorectal Cancer

More than 90,000 men and women are diagnosed with colorectal cancer in the United States each year, resulting in more than 50,000 deaths. Surgery and chemotherapy are generally used to treat colorectal cancer.


SC-006 is an antibody drug conjugate in development for colorectal cancer. A Phase 1a clinical trial (NCT03035279) is ongoing and available for enrollment.